MDC 0.00% $6.60 medlab clinical limited

Ann: Reminder of Investor Webinar - NanaBis Phase III Trial, page-17

  1. 4,445 Posts.
    lightbulb Created with Sketch. 337
    Very strange. Is easy for MDC to be sold down (on purpose) as all the interest is diverted into MXC CPH LGP. Almost like they are seeing how investors react to the shocking sell down yesterday. Pick the bottom..

    Current value of MDC is $68million AUS. Is this super cheap or super expensive? That is the question.

    Considering MDC was holding strong not long ago at 0.35c to 0.40c i would say this sell down and deliberate raise at 0.24c is all by design before UK US & AU phase3 trial gains US,UK & AU interest. At current i think MDC only has Australian investor interest and is why buy depth is thin and easy to wipe out 50% of company value in a matter of weeks from a relatively small sell down of shares to bring out more seller's for 'insider' accumulation IMO> See what happens but going on the large exits for shock value, something is definitely brewing.

    If they sell it down to 0.15c for example the company will have a value of $45million AUS. Super cheap?

    If the phase3 trial attracts US, AU & UK investors will $40mill-$68mill AU be cheap or expensive? Considering MXC is $140mill and CPH is $210mill.

    Let's wait and see what happens.
 
watchlist Created with Sketch. Add MDC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.